switching from semaglutide to liraglutide Vs | Wegovy Vs Saxenda Semaglutide vs Liraglutide vs Tirzepatide

The findings come as scientists are exploring new uses for GLP-1s beyond weight loss and diabetes management

Despite this, the Wegovy pill launched in January 2026, and Hims was not on the partner list

GLP-1 medications (Zepbound, Wegovy) produce significantly greater long-term weight loss, have metabolic and cardiovascular benefits, are approved for chronic use, and are more appropriate for patients with obesity-related health conditions who need ongoing treatment

At the time, despite evidence suggesting a link between EBV infection and MS, the cause of the disease remained unknown (6)

Pricing Pressure Becomes Part of the System If the early GLP-1 era was defined by sticker shock, 2026 marks the point where pricing pressure becomes structural